Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Soy Protein and Reduced C-Reactive Protein Levels

Research synthesisLow evidenceMixed effect size3 studies · 1 beneficial · 2 neutral · 0 harmful

Across 3 studies, one meta-analysis reported a moderate beneficial effect of soy protein on reducing C-reactive protein (CRP) in adults with chronic inflammatory diseases, while two other studies (a meta-analysis and an RCT) found no significant effect. The predominant effect size is mixed (small to moderate). The median study duration was 90 days, and the most studied dose was 40 g/day.

  • Studied populations: Adults with chronic inflammatory diseases

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance, suggesting the effect may be inconsistent. The beneficial effect was observed only in a meta-analysis of patients with chronic inflammatory diseases; the effect may not generalize to other populations.

Generated Jul 11, 2026
Doses used in studies
  • g/day: 40 (median 40, IQR 4040) 1 study
Time to effect
Median: 3 months · IQR 3 months3 months · Range 3 months3 months — Reported in 1 of 3 studies
3 of 3 papers
Back to top